2-甲基-4-羟基苯并咪唑 | 94977-60-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: 2-甲基-4-羟基苯并咪唑
• 中文别名: 2-甲基-1H-苯并[D]咪唑-7-醇
• 英文名称: 2-methyl-4-hydroxybenzimidazole
• 英文别名: 2-methyl-1H-benzo[d]imidazol-4-ol；4-hydroxy-2-methylbenzimidazole；2-methyl-1(3)H-benzoimidazol-4-ol；2-methyl-1(3)H-benzimidazol-4-ol；2-Methyl-1H-benzo[d]imidazol-7-ol；2-methyl-1H-benzimidazol-4-ol
• CAS: 94977-60-3
• 化学式: C₈H₈N₂O
• mdl: MFCD21333159
• 分子量: 148.164
• InChiKey: HLPAESMITTURFN-UHFFFAOYSA-N

物化性质

• 熔点：
  211 °C (decomp)(Solv: ethyl acetate (141-78-6))
• 沸点：
  432.2±18.0 °C(Predicted)
• 密度：
  1.349±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  48.9
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1-[(2R)-4-benzoyl-2-methyl-piperazin-1-yl]-2-bromo-propan-1-one 、 2-甲基-4-羟基苯并咪唑 在 caesium carbonate 作用下， 以 丙酮 为溶剂， 反应 24.0h， 生成 1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[(2-methyl-1H-benzimidazol-4-yl)oxy]propan-1-one
  参考文献：
  名称：

  Design and optimisation of potent gp120-CD4 inhibitors

  摘要：

  The synthesis and structure-activity relationship of a series of novel gp120-CD4 inhibitors are described. Pharmacokinetic studies and antiviral spectrum assessment of lead compounds led to the identification of compound 36, a potent gp120-CD4 inhibitor which exhibited antiviral potency across a spectrum of 25 clade B isolates. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.06.102
• 作为产物：
  描述：

  N-(2-Acetylamino-6-hydroxy-phenyl)-acetamide 在 sodium hydroxide 作用下， 生成 2-甲基-4-羟基苯并咪唑
  参考文献：
  名称：

  Derivatives of benzimidazoles active as anti-ulcer agents

  摘要：

  通用公式I的新化合物，其制备方法，含有这种化合物作为活性成分的药物组合物以及这些化合物在医学中的用途。

  公开号：

  US05106862A1

文献信息

• [EN] INSECTICIDAL DIAZOLE AND TRIAZOLE DERIVATIVES<br/>[FR] DERIVES DE DIAZOLE ET DE TRIAZOLE INSECTICIDES
  申请人：FMC CORP

  公开号：WO2005108374A1

  公开（公告）日：2005-11-17

  It has now been found that certain novel diazole and triazole derivatives have provided unexpected insecticidal activity. These compounds are represented by formula (I). Preferred are those compounds of formula (I) where M and Q are carbon; R is methyl; R1 and R2 taken together are -CH=CHCH=CH-, -C(Cl)=CHCH=CH-, -C(F)=CHCH=CH-, or -C(CH3)=CHCH=CH-; X is straight or branched chain alkylenyl; Y is phenyl; and R4 is one or more hydrogen, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, cyano, amino, or -(O)t-(CH2)v-Z-R6, where Z is -C(R7)=C(R8)-, -C≡C-, or -C(R7)=NO-; and, R6, R7 and R8 are indepdently hydrogen, halogen, or alky. In addition, compositions comprising an insecticidally effective amount of at least one compound of formula (I), and optionally, an effective amount of at least one of a second compound, with at least one insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to the locus of crops where insects are present or are expected to be present.

  已经发现了某些新型二唑和三唑衍生物具有意想不到的杀虫活性。这些化合物由式(I)表示。首选的是式(I)中M和Q为碳；R为甲基；R1和R2一起取-CH=CHCH=CH-, -C(Cl)=CHCH=CH-, -C(F)=CHCH=CH-或-C(CH3)=CHCH=CH-；X为直链或支链烷基；Y为苯基；R4为一个或多个氢、卤素、烷基、卤代烷基、烷氧基、卤代烷氧基、氰基、氨基或-(O)t-(CH2)v-Z-R6，其中Z为-C(R7)=C(R8)-，-C≡C-或-C(R7)=NO-；而R6、R7和R8独立地为氢、卤素或烷基。此外，还公开了包含至少一种式(I)化合物的杀虫有效量和可选地至少一种第二化合物的有效量，以及至少一种杀虫载体的组合物；以及涉及将这些组合物施用于存在或预计存在昆虫的作物生长地点以控制昆虫的方法。
• Vanilloid receptor ligands and their use in treatments
  申请人：Wang Hui-Ling

  公开号：US20050176726A1

  公开（公告）日：2005-08-11

  Pyrimidine ethers and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

  嘌呤醚及含有它们的组合物，用于治疗急性、炎症性和神经痛、牙痛、普通头痛、偏头痛、集群头痛、混合血管和非血管综合症、紧张性头痛、一般炎症、关节炎、风湿病、骨关节炎、炎症性肠道疾病、炎症性眼部疾病、炎症性或不稳定的膀胱疾病、牛皮癣、伴有炎症成分的皮肤问题、慢性炎症症状、炎症性疼痛及相关的过敏性疼痛和触痛、神经痛及相关的过敏性疼痛和触痛、糖尿病性神经病痛、烧灼性疼痛、交感神经维持性疼痛、感觉缺失综合症、哮喘、上皮组织损伤或功能障碍、单纯疱疹、呼吸、泌尿生殖、胃肠或血管区域内脏运动障碍、伤口、烧伤、过敏性皮肤反应、瘙痒、白癜风、一般胃肠道紊乱、胃溃疡、十二指肠溃疡、腹泻、由坏死剂引起的胃损伤、毛发生长、血管运动性或过敏性鼻炎、支气管疾病或膀胱疾病。
• Benzyl-substituted benzimidazoles
  申请人：AstraZeneca AB

  公开号：US06465505B1

  公开（公告）日：2002-10-15

  The present invention relates to benzimidazole derivatives of the formula (I), in which the phenyl moiety is substituted with lower alkyl in 2- and 6-position, which inhibit exogenously or endogenously stimulated gastric acid secretion and thus can be used in the prevention and treatment of gastrointestinal inflammatory diseases.

  本发明涉及式(I)的苯并咪唑衍生物，其中苯基部分在2-和6-位置被低碳烷基取代，这些衍生物能抑制外源性或内源性刺激引起的胃酸分泌，因此可用于预防和治疗胃肠道炎症性疾病。
• Dyeing compositions for keratinous fibres containing paraphenylenediamine derivatives with pyrrolidinyl group
  申请人：——

  公开号：US20030093866A1

  公开（公告）日：2003-05-22

  The invention concerns novel dyeing compositions for keratinous fibers comprising at least a paraphenylenediamine derivative with pyrrolidinyl group as oxidation base, a dyeing method and a dyeing kit using said composition.

  该发明涉及一种用于角蛋白纤维的新型染色组合物，包括至少一种带有吡咯啉基团的对苯二胺衍生物作为氧化剂基础，一种染色方法和使用该组合物的染色套件。
• Salicylamides as serine protease inhibitors
  申请人：——

  公开号：US20020052343A1

  公开（公告）日：2002-05-02

  The present invention provides novel compounds of Formula I: 1 its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of serine proteases, Urokinase (uPA), Factor Xa (FXa), and/or Factor VIIa (FVIIa), and have utility as anti cancer agents and/or as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals. The present invention also provides a process for the selective acylation of an amino group.

  本发明提供了Formula I的新化合物、其前药形式或其药用可接受的盐。本发明的化合物是丝氨酸蛋白酶、尿激酶（uPA）、凝血因子Xa（FXa）和/或凝血因子VIIa（FVIIa）的抑制剂，并且具有作为抗癌剂和/或抗凝剂在哺乳动物中治疗或预防血栓栓塞性疾病的用途。本发明还提供了一种选择性酰化氨基团的方法。